Venture Capital

Lemurian Labs adds tech legends Kim Polese and Saman Amarasinghe, betting on deep systems expertise to solve AI's fragmentation and platform lock-in.

With new CRO and CPO hires, Affinity signals an aggressive push to dominate the private capital CRM market with its AI-powered relationship intelligence platform.

Fortune 500 leaders will convene in Detroit to chart the future of American business, tackling AI transformation and celebrating 250 years of innovation.

As SaaS data breaches rise, K1's investment in Spin.AI highlights the urgent need for AI-driven security and its industry-leading 2-hour ransomware recovery.

The publisher reveals a massive ARK universe expansion, a new AAA space RPG, and a venture into interactive films in a bold, multi-front strategy.

AVANCE Global and We Are All Human merge their influential platforms, creating a new epicenter for celebrating Hispanic economic and cultural achievement.

A landmark study validated by Optum shows a virtual care model for women saves thousands, shifting benefits from a cost center to a strategic investment.

The deal with Ahngook Pharm for its GMRx2 single-pill therapy marks a key step in a global strategy validated by recent US FDA approval.

Inc. names Dia Simms and Erin J. Hall to its Female Founders 500, validating Pronghorn’s model that investing in diversity is simply good business.

Robotics firm Genesis AI taps autonomous driving expert Vivian Sun to lead its push from R&D to market, signaling a new era for 'physical AI' automation.

Dr. Yulun Wang, inventor of the first FDA-approved surgical robot, joins AiM Medical Robotics, signaling a major leap forward for MRI-guided brain surgery.

Chowbus lands $81M to arm culturally rooted restaurants with powerful AI tools, aiming to level the playing field against large corporate chains.

With $59M in total funding, the defense tech startup is scaling up production of large UAVs and AI-driven software to revolutionize American air power.

With a massive new investment, Vima Therapeutics advances a first-in-class oral drug into Phase 2, offering new hope beyond injections and surgery.

As the oral stimulant pouch market booms, Doseology Sciences Inc. uplists to the OTCQB to capture U.S. investors and a new wave of consumers.

IQM's new quantum computer at Aalto University will train future talent, integrate with supercomputers, and cement Finland's status as a top quantum hub.

After a major strategic pivot, the racing game developer posts a $6.8M net income, proving the success of its focused, simulation-first approach.

With a strong cash position and new leadership, Artiva pivots its AlloNK® cell therapy to autoimmune disease, targeting a pivotal trial for RA in 2026.

A new fellowship at the Institut Pasteur aims to revolutionize public health by training scientists in what its founder calls the '3Ms': Money, Management, and Medicine.

As ground travel surges, new data-driven awards from Busbud reveal the operators leading in service, comfort, and reliability. See who made the cut.